-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UMoBwDD2ppb5/v8fY1EmIuYBa4LadyMI3FqcDtJF4S1cDWDEMUjU6J0jX8tvTE6V P1bwd6bYs7bH6WCYMHxowA== 0001225208-10-006486.txt : 20100302 0001225208-10-006486.hdr.sgml : 20100302 20100302131746 ACCESSION NUMBER: 0001225208-10-006486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100301 FILED AS OF DATE: 20100302 DATE AS OF CHANGE: 20100302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC CENTRAL INDEX KEY: 0000901219 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 223178468 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850-3338 BUSINESS PHONE: 3013098504 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bateson Susan D. CENTRAL INDEX KEY: 0001191234 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14169 FILM NUMBER: 10648285 MAIL ADDRESS: STREET 1: 14200 SHADY GROVE ROAD CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER NAME: FORMER CONFORMED NAME: MCKAY SUSAN D BATESON DATE OF NAME CHANGE: 20020920 4 1 doc4.xml X0303 4 2010-03-01 0000901219 HUMAN GENOME SCIENCES INC HGSI 0001191234 Bateson Susan D. 14200 SHADY GROVE ROAD ROCKVILLE MD 20850 1 Senior Vice President Common Stock 2010-03-01 4 M 0 85200 12.56 A 145558 D Common Stock 2010-03-01 4 S 0 85200 28.0811 D 60358 D Employee Stock Option - Right to Buy 12.56 2010-03-01 4 M 0 85200 0 D 2010-04-07 Common Stock 85200 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/10/09. This transaction was executed in multiple trades at prices ranging from $27.93 to $28.21. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available. These are fully vested and exercisable. /s/ Susan D. Bateson 2010-03-02 -----END PRIVACY-ENHANCED MESSAGE-----